| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | potassium channel activator activity | 1.96e-04 | 6 | 73 | 2 | GO:0099104 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 2.16e-04 | 149 | 73 | 5 | GO:1990782 | |
| GeneOntologyMolecularFunction | receptor tyrosine kinase binding | 3.31e-04 | 90 | 73 | 4 | GO:0030971 | |
| GeneOntologyMolecularFunction | channel activator activity | 5.82e-04 | 10 | 73 | 2 | GO:0099103 | |
| GeneOntologyBiologicalProcess | epithelial to mesenchymal transition | 6.29e-06 | 203 | 71 | 7 | GO:0001837 | |
| GeneOntologyBiologicalProcess | mesenchymal cell differentiation | 7.95e-06 | 296 | 71 | 8 | GO:0048762 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 4.10e-05 | 372 | 71 | 8 | GO:0060485 | |
| Domain | fn3 | 3.32e-04 | 162 | 69 | 5 | PF00041 | |
| Domain | FN3 | 6.08e-04 | 185 | 69 | 5 | SM00060 | |
| Domain | FN3 | 8.45e-04 | 199 | 69 | 5 | PS50853 | |
| Domain | FN3_dom | 1.05e-03 | 209 | 69 | 5 | IPR003961 | |
| Domain | CH | 1.79e-03 | 65 | 69 | 3 | SM00033 | |
| Domain | CH | 2.21e-03 | 70 | 69 | 3 | PF00307 | |
| Domain | - | 2.30e-03 | 71 | 69 | 3 | 1.10.418.10 | |
| Domain | CH | 2.49e-03 | 73 | 69 | 3 | PS50021 | |
| Domain | CH-domain | 2.69e-03 | 75 | 69 | 3 | IPR001715 | |
| Pubmed | P53 independent pathogenic mechanisms contribute to BubR1 microcephaly. | 3.18e-06 | 14 | 73 | 3 | 37900274 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 35774082 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 33859071 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 12242304 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 31597725 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 17433324 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 22765508 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 26102039 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 16818635 | ||
| Pubmed | Telomerase reverse transcriptase mutation and the p53 pathway in T1 urinary bladder cancer. | 4.35e-06 | 2 | 73 | 2 | 34028171 | |
| Pubmed | Expression of Evc2 in craniofacial tissues and craniofacial bone defects in Evc2 knockout mouse. | 4.35e-06 | 2 | 73 | 2 | 27164562 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 34381934 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 31936650 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 36926116 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 11788906 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 28137912 | ||
| Pubmed | p53-dependent integration of telomere and growth factor deprivation signals. | 4.35e-06 | 2 | 73 | 2 | 17360541 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 35830790 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 34001963 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 16651430 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 34831112 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 17855516 | ||
| Pubmed | 4.87e-06 | 16 | 73 | 3 | 36127134 | ||
| Pubmed | Mucocutaneous inflammation in the Ikaros Family Zinc Finger 1-keratin 5-specific transgenic mice. | 4.87e-06 | 16 | 73 | 3 | 28914974 | |
| Pubmed | 5.60e-06 | 120 | 73 | 5 | 21697133 | ||
| Pubmed | 8.13e-06 | 225 | 73 | 6 | 12168954 | ||
| Pubmed | Yap/Taz are required for establishing the cerebellar radial glia scaffold and proper foliation. | 8.39e-06 | 19 | 73 | 3 | 31586559 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 17828505 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 26553052 | ||
| Pubmed | p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma. | 1.30e-05 | 3 | 73 | 2 | 12496479 | |
| Pubmed | Telomerase reverse transcriptase delays aging in cancer-resistant mice. | 1.30e-05 | 3 | 73 | 2 | 19013273 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 20032382 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 12508351 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 10594015 | ||
| Pubmed | A crucial role for adipose tissue p53 in the regulation of insulin resistance. | 1.30e-05 | 3 | 73 | 2 | 19718037 | |
| Pubmed | Enriched expression of genes associated with autism spectrum disorders in human inhibitory neurons. | 1.30e-05 | 3 | 73 | 2 | 29317598 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 23677994 | ||
| Pubmed | Loss of p53 function through PAX-mediated transcriptional repression. | 1.30e-05 | 3 | 73 | 2 | 8521821 | |
| Pubmed | Emerging role of p53, bcl-2 and telomerase activity in Egyptian breast cancer patients. | 1.30e-05 | 3 | 73 | 2 | 15545228 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 35550247 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 18843043 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 21572399 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 17460194 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 36446779 | ||
| Pubmed | CYP26B1 declines postnatally in Sertoli cells independently of androgen action in the mouse testis. | 1.30e-05 | 3 | 73 | 2 | 31755607 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 18223681 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 17974918 | ||
| Pubmed | Telomerase suppression initiates PML-dependent p53 activation to inhibit bladder cancer cell growth. | 1.30e-05 | 3 | 73 | 2 | 21042751 | |
| Pubmed | MYC amplification and TERT expression in breast tumor progression. | 1.30e-05 | 3 | 73 | 2 | 17656250 | |
| Pubmed | RNF43 interacts with NEDL1 and regulates p53-mediated transcription. | 1.30e-05 | 3 | 73 | 2 | 21108931 | |
| Pubmed | UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma. | 1.30e-05 | 3 | 73 | 2 | 37407562 | |
| Pubmed | PinX1, a novel target gene of p53, is suppressed by HPV16 E6 in cervical cancer cells. | 1.30e-05 | 3 | 73 | 2 | 24412852 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 12452037 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 28613007 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 28627647 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 23106581 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 14743210 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 18626023 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 34292326 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 20628269 | ||
| Pubmed | A critical role for Sox9 in notch-induced astrogliogenesis and stem cell maintenance. | 1.30e-05 | 3 | 73 | 2 | 23307615 | |
| Pubmed | hTERT, MYC and TP53 deregulation in gastric preneoplastic lesions. | 1.30e-05 | 3 | 73 | 2 | 22768805 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 29950351 | ||
| Pubmed | The Hippo Pathway Prevents YAP/TAZ-Driven Hypertranscription and Controls Neural Progenitor Number. | 1.74e-05 | 24 | 73 | 3 | 30523785 | |
| Pubmed | 2.06e-05 | 157 | 73 | 5 | 30186101 | ||
| Pubmed | Actinfilin, a brain-specific actin-binding protein in postsynaptic density. | 2.60e-05 | 4 | 73 | 2 | 12063253 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 19787269 | ||
| Pubmed | p53-dependent down-regulation of telomerase is mediated by p21waf1. | 2.60e-05 | 4 | 73 | 2 | 15371422 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 12077343 | ||
| Pubmed | Single-cell, whole-embryo phenotyping of mammalian developmental disorders. | 2.60e-05 | 4 | 73 | 2 | 37968388 | |
| Pubmed | Primate-specific RFPL1 gene controls cell-cycle progression through cyclin B1/Cdc2 degradation. | 2.60e-05 | 4 | 73 | 2 | 20725088 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 24633336 | ||
| Pubmed | Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ. | 2.60e-05 | 4 | 73 | 2 | 28166194 | |
| Pubmed | Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumours. | 2.60e-05 | 4 | 73 | 2 | 14532990 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 22341455 | ||
| Pubmed | Interaction of Pax6 with SPARC and p53 in brain of mice indicates Smad3 dependent auto-regulation. | 2.60e-05 | 4 | 73 | 2 | 20177825 | |
| Pubmed | Telomere Dysfunction Induces Sirtuin Repression that Drives Telomere-Dependent Disease. | 2.60e-05 | 4 | 73 | 2 | 30930169 | |
| Pubmed | G9a and Glp methylate lysine 373 in the tumor suppressor p53. | 2.60e-05 | 4 | 73 | 2 | 20118233 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 17145779 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 21436583 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 29986868 | ||
| Pubmed | 3.12e-05 | 29 | 73 | 3 | 27358050 | ||
| Pubmed | 3.12e-05 | 29 | 73 | 3 | 28049658 | ||
| Pubmed | 3.46e-05 | 30 | 73 | 3 | 21826226 | ||
| Pubmed | 3.82e-05 | 31 | 73 | 3 | 36362374 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 29511023 | ||
| Pubmed | Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma. | 4.33e-05 | 5 | 73 | 2 | 27281208 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 25099011 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 29026176 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 27216178 | ||
| Pubmed | beta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53. | 4.33e-05 | 5 | 73 | 2 | 17984062 | |
| Pubmed | Dual regulation of TERT activity through transcription and splicing by DeltaNP63alpha. | 4.33e-05 | 5 | 73 | 2 | 20157588 | |
| Pubmed | CHD8 suppresses p53-mediated apoptosis through histone H1 recruitment during early embryogenesis. | 4.33e-05 | 5 | 73 | 2 | 19151705 | |
| Pubmed | Cellular mechanisms underlying Pax3-related neural tube defects and their prevention by folic acid. | 4.33e-05 | 5 | 73 | 2 | 31636139 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 17198740 | ||
| Pubmed | Gfi1b regulates the level of Wnt/β-catenin signaling in hematopoietic stem cells and megakaryocytes. | 5.07e-05 | 34 | 73 | 3 | 30894540 | |
| Pubmed | 6.03e-05 | 36 | 73 | 3 | 38078651 | ||
| Pubmed | The BRG1/SOX9 axis is critical for acinar cell-derived pancreatic tumorigenesis. | 6.48e-05 | 6 | 73 | 2 | 30010625 | |
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 29604291 | ||
| Pubmed | Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas. | 6.48e-05 | 6 | 73 | 2 | 36443313 | |
| GeneFamily | Fibronectin type III domain containing | 4.19e-05 | 160 | 44 | 5 | 555 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_mature_2|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.48e-06 | 131 | 73 | 5 | f2eee150f5cff852e8f52f09b35e26f17d80833b | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-06 | 151 | 73 | 5 | ced4f7ee377a23a804ae6fde624e8b55b79f1fd8 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-06 | 151 | 73 | 5 | b52bb3b88e9a6473f571053537b8beb418678539 | |
| ToppCell | Club_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 6.80e-06 | 161 | 73 | 5 | 342f5c61d37df61b35c18f5d258043a8f5cef629 | |
| ToppCell | BAL-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 8.13e-06 | 167 | 73 | 5 | 6c5aa9077ae7eb8887269d405972bd5b31596b19 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-06 | 173 | 73 | 5 | a5172dee859bf6c2eed46c48bd64dfef0ff9f28f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-06 | 173 | 73 | 5 | 639b5b0b33ce5aa0bc26363c059717012ddc14c0 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.64e-06 | 173 | 73 | 5 | 4968712af1cca8c932abd3323631d7dcaffd4a66 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-05 | 179 | 73 | 5 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-05 | 181 | 73 | 5 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.30e-05 | 184 | 73 | 5 | 97e97de52daaff8840f4ee76a94ba5e3f79de7ce | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-05 | 186 | 73 | 5 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.63e-05 | 193 | 73 | 5 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.89e-05 | 199 | 73 | 5 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | Sigmoid-T_cell-gd_T|T_cell / Region, Cell class and subclass | 1.94e-05 | 200 | 73 | 5 | 20844293c155d3f319ceeea9476979bc86515b53 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Sc17a7.Tshz2-Smoc1_(Agranular_Retrosplenial_cortex_(RSG)_(Smoc1+))-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.16e-05 | 49 | 73 | 3 | 4845246699a56fea657fd2697b612e93248f590f | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Sc17a7.Tshz2-Smoc1_(Agranular_Retrosplenial_cortex_(RSG)_(Smoc1+))|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.16e-05 | 49 | 73 | 3 | 5f1c5ebb6f113513b7e6945dfab07c3c34ebab41 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D2|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.48e-05 | 145 | 73 | 4 | 3a34c25ff77cd33fdca84742097cc7484066ebc4 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Monocytic-Cycling_mono|bone_marrow / Manually curated celltypes from each tissue | 1.03e-04 | 148 | 73 | 4 | de35eeefad0e27a0d127e2e4bedead2bddb75152 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-neutrophil-neutrophil|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-04 | 153 | 73 | 4 | ce6e462ce4dbaf9d265f1f9e2f791efbba8c1dd0 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-neutrophil|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-04 | 153 | 73 | 4 | 9dba38574908f31a1194b8a339868f5e4be1be71 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 155 | 73 | 4 | 5d157478669b609e1f0f0a75afd0112571fc2c46 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-04 | 157 | 73 | 4 | bd45590da540a557dc8096980a45220fccb99505 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 157 | 73 | 4 | 0673c7161c25feceee8f1e5fd237171576c42c6b | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 157 | 73 | 4 | d307d0b48af35e0e1af41ecd3ebf91be8fd29dc0 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-04 | 157 | 73 | 4 | 00c9a58b033b8b95b0d838f233dd077b62d8b02a | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 158 | 73 | 4 | 30cceb73cf5e24b692da84d33342fd3b1ad5efe5 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 158 | 73 | 4 | 47793463640f98ee5f680a1ee5786b453355fd57 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 159 | 73 | 4 | baf843dc44b072504eb1d28de55b1ee67aeec32b | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 159 | 73 | 4 | 9eb78202b9a4e8217f00e64d5142ed28c00abd04 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.42e-04 | 161 | 73 | 4 | 0d863d7d369391dd6148e1de6d6f8033dcb8fe0f | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 161 | 73 | 4 | 60f433eab9d5531bdf6aa86b0265f20b866b904c | |
| ToppCell | droplet-Fat-Gat-18m-Myeloid-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 163 | 73 | 4 | 3d12a8ca97005308403a3ab136af483ab25f9b0e | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 164 | 73 | 4 | 8e6dbddacd56a07769163813e3ebfad13302bb62 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 165 | 73 | 4 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 165 | 73 | 4 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-04 | 168 | 73 | 4 | 937332580a522826b820e0b09080013f19f58479 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 168 | 73 | 4 | 3611605114f6b668b44728d6563cd02389e106af | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_C|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-04 | 168 | 73 | 4 | 0372c06b70f0ba95bf8cd1363ca7c5f31207f094 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-neutrophil-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-04 | 168 | 73 | 4 | b0376e3687fa85f091654196403eecedc219d0cd | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 169 | 73 | 4 | f38b52972a6c492ce2fd520a26bb3fc8db23bf85 | |
| ToppCell | facs-Marrow-Granulocytes-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 169 | 73 | 4 | ee1969755180df58d32904e2bb4192da9373d03e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Microfold_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-04 | 169 | 73 | 4 | a54a8494c1feff29d77ab4737fcfabc84ace5c94 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 169 | 73 | 4 | 5320da1d61806b53e0bd96bbdfdb8fd69246681b | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 169 | 73 | 4 | 2341eddfedaad8cee779c37bb87f7def058588ca | |
| ToppCell | facs-Marrow-Granulocytes-18m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 169 | 73 | 4 | 94871936ccfc73b56d425373b989b87c059d4493 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.75e-04 | 170 | 73 | 4 | aabe993c9f337b1caaeb0e64626a3920579c41b7 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Myeloid|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 170 | 73 | 4 | d582087a983fe20d811d92f0de0458f3cfd71d2b | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Myeloid-macrophage|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 170 | 73 | 4 | dfbe7ba11b867a4e10fa915f282a2e5cb2f5fb8c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 171 | 73 | 4 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | facs-Marrow-Granulocytes|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 171 | 73 | 4 | 1701dedf0c18751db6c9fee3d93fff150ed0e17f | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 171 | 73 | 4 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Myeloid-new-cluster|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 171 | 73 | 4 | d0d92eb5152410c3b4dd4a3f1dc3cca0e18a85fd | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 173 | 73 | 4 | 0f9784b30c81a4a4940e0623cec60d596e9985d2 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 173 | 73 | 4 | 60f79e0698a7cf7516690fb20f1b82ee46547699 | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 173 | 73 | 4 | 03cee3d24bc433e91a867ce951589de64a0538af | |
| ToppCell | Healthy_donor-Plasmablast|World / disease group, cell group and cell class (v2) | 1.95e-04 | 175 | 73 | 4 | 5293e00fda63a291aa393bdf82ebd4b80265049f | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 176 | 73 | 4 | 24b2e94ee5defcefb64a1f2447a2cc71b015b0fd | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 176 | 73 | 4 | f7d8eb90489a6d22240179abeb0aa16ac24615d3 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 177 | 73 | 4 | 065bebd22031f143e90a407f952b444a3f8818c7 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-04 | 177 | 73 | 4 | f360f7099570d248531897b96e0de282e58f59e9 | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 177 | 73 | 4 | 5d70fe2b0592362d664b3b4c84eb450ec2335957 | |
| ToppCell | facs-Marrow-Granulocytes-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 177 | 73 | 4 | eb304f20aab075bd17aa3aef819386c0e1a235bd | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 177 | 73 | 4 | 48bcf603ec9593eedd81f3831cf9fde89fad368f | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-04 | 177 | 73 | 4 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | Healthy_donor-Plasmablast|Healthy_donor / disease group, cell group and cell class (v2) | 2.08e-04 | 178 | 73 | 4 | 388b8b4fa20dcc6e9ae4b06118e20b2c20c52bde | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-04 | 179 | 73 | 4 | e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 2.13e-04 | 179 | 73 | 4 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Smooth_muscle|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.17e-04 | 180 | 73 | 4 | 7085a851807e6a833965e1366946db0bbc5174e2 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 180 | 73 | 4 | 79c5725f02e038d0187f4a1e1591f2492538aa57 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.22e-04 | 181 | 73 | 4 | c7a220891567c7539ad5a9ac9db375f0de08ea00 | |
| ToppCell | lymphoid-T_cell-CD8+_Effector_T_cell|World / Lineage, cell class and subclass | 2.22e-04 | 181 | 73 | 4 | de4c5b043d743a93f2b0864b178aed0947b9af62 | |
| ToppCell | lymphoid-T_cell-CD8+_Effector_T_cell|lymphoid / Lineage, cell class and subclass | 2.27e-04 | 182 | 73 | 4 | d4ef4a7c0f5dc044eb5cc6c0bcf539c88b1b4fef | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.32e-04 | 183 | 73 | 4 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 2.32e-04 | 183 | 73 | 4 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-04 | 183 | 73 | 4 | 263937906ddabc798bbe60f0da28ba859a5c72e2 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.36e-04 | 184 | 73 | 4 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.36e-04 | 184 | 73 | 4 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.36e-04 | 184 | 73 | 4 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.41e-04 | 185 | 73 | 4 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.41e-04 | 185 | 73 | 4 | 68f428e169cfb77de970bdfdeea9b9f16f68d2ba | |
| ToppCell | facs-Marrow|facs / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-04 | 185 | 73 | 4 | e40f0a0439834c3025d6c7832977be4e37a94c44 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.41e-04 | 185 | 73 | 4 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.41e-04 | 185 | 73 | 4 | dd17025d8c423aa0a451ac7f1f301c93528e0229 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.46e-04 | 186 | 73 | 4 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 2.46e-04 | 186 | 73 | 4 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue | 2.51e-04 | 187 | 73 | 4 | 3c10b8501226c69d71bcd99dc1c064a3c2154f87 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.51e-04 | 187 | 73 | 4 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-04 | 187 | 73 | 4 | 3912bbb610a4a84791e9bda92a2d57a52c31d29e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.57e-04 | 188 | 73 | 4 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-04 | 188 | 73 | 4 | fa7a612b0a2b35de5f76a0408168dabe5db00773 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.57e-04 | 188 | 73 | 4 | 3004e961d214919e08c7cd5f10c3de5cf85b35a3 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-04 | 189 | 73 | 4 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-04 | 189 | 73 | 4 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.67e-04 | 190 | 73 | 4 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-04 | 191 | 73 | 4 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-04 | 191 | 73 | 4 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.72e-04 | 191 | 73 | 4 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 2.78e-04 | 192 | 73 | 4 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| Disease | Malignant neoplasm of breast | FNDC3B FLNA COL7A1 FCRL3 TMTC4 CEP85L PDZK1 KBTBD8 EHMT1 MSI1 TERT TP53 | 8.98e-06 | 1074 | 71 | 12 | C0006142 |
| Disease | CHARGE syndrome (implicated_via_orthology) | 1.19e-04 | 7 | 71 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | age at onset, glioblastoma multiforme | 1.58e-04 | 8 | 71 | 2 | EFO_0000519, EFO_0004847 | |
| Disease | uterine fibroid, Menorrhagia | 2.03e-04 | 9 | 71 | 2 | EFO_0000731, HP_0000132 | |
| Disease | glioblastoma multiforme | 2.03e-04 | 9 | 71 | 2 | EFO_0000519 | |
| Disease | Congenital neurologic anomalies | 2.54e-04 | 10 | 71 | 2 | C0497552 | |
| Disease | Cranioschisis | 2.54e-04 | 10 | 71 | 2 | C0265541 | |
| Disease | triple-negative breast cancer | 2.54e-04 | 10 | 71 | 2 | EFO_0005537 | |
| Disease | Uterine leiomyoma, estrogen-receptor negative breast cancer | 2.54e-04 | 10 | 71 | 2 | EFO_1000650, HP_0000131 | |
| Disease | fructose measurement, glucose measurement, galactose measurement | 3.71e-04 | 12 | 71 | 2 | EFO_0004468, EFO_0010477, EFO_0010481 | |
| Disease | Myeloproliferative disease | 3.71e-04 | 12 | 71 | 2 | C0027022 | |
| Disease | central nervous system cancer, glioblastoma multiforme | 5.10e-04 | 14 | 71 | 2 | EFO_0000326, EFO_0000519 | |
| Disease | Malignant Glioma | 6.51e-04 | 70 | 71 | 3 | C0555198 | |
| Disease | mixed gliomas | 6.51e-04 | 70 | 71 | 3 | C0259783 | |
| Disease | Disease Exacerbation | 6.84e-04 | 165 | 71 | 4 | C0235874 | |
| Disease | glucuronate measurement | 8.52e-04 | 18 | 71 | 2 | EFO_0010486 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 8.52e-04 | 18 | 71 | 2 | EFO_1000649, HP_0000131 | |
| Disease | Adrenocortical carcinoma | 8.52e-04 | 18 | 71 | 2 | C0206686 | |
| Disease | Disproportionate short stature | 8.60e-04 | 77 | 71 | 3 | C0878659 | |
| Disease | myelodysplastic syndrome (is_marker_for) | 1.05e-03 | 20 | 71 | 2 | DOID:0050908 (is_marker_for) | |
| Disease | Glioma | 1.22e-03 | 87 | 71 | 3 | C0017638 | |
| Disease | renal system measurement, blood urea nitrogen measurement | 1.28e-03 | 22 | 71 | 2 | EFO_0004741, EFO_0004742 | |
| Disease | glioma | 1.28e-03 | 22 | 71 | 2 | EFO_0005543 | |
| Disease | urate measurement | 1.37e-03 | 895 | 71 | 8 | EFO_0004531 | |
| Disease | hypertrophic cardiomyopathy | 1.44e-03 | 92 | 71 | 3 | EFO_0000538 | |
| Disease | cataract (is_implicated_in) | 1.79e-03 | 26 | 71 | 2 | DOID:83 (is_implicated_in) | |
| Disease | Adenoid Cystic Carcinoma | 1.83e-03 | 100 | 71 | 3 | C0010606 | |
| Disease | Pigmented Basal Cell Carcinoma | 2.07e-03 | 28 | 71 | 2 | C1368275 | |
| Disease | oral squamous cell carcinoma (is_implicated_in) | 2.07e-03 | 28 | 71 | 2 | DOID:0050866 (is_implicated_in) | |
| Disease | Carcinoma, Basal Cell | 2.22e-03 | 29 | 71 | 2 | C4721806 | |
| Disease | central nervous system cancer, glioma | 2.22e-03 | 29 | 71 | 2 | EFO_0000326, EFO_0005543 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 2.27e-03 | 108 | 71 | 3 | DOID:684 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NTTRVMGWIPPGQCR | 226 | P60509 | |
| WPSSRRSQEMVTGGI | 2176 | Q9HCK8 | |
| MSSWSRQRPKSPGGI | 1 | P02750 | |
| WRRAVSTGVQAGIPM | 406 | P52209 | |
| SMGLRPLPAATVGRW | 261 | Q569K6 | |
| PINMPWLGSTQTGRG | 2721 | Q9Y485 | |
| PVMNGGVQTWTQPRL | 121 | Q5T2W1 | |
| LRMLNGQTGSWGTRP | 146 | P26367 | |
| MPITKSSRGAGWRRP | 906 | Q9C0D6 | |
| CSMVGQPVRRWRSPG | 281 | Q6W4X9 | |
| MARWRGPTQSVGPTI | 16 | Q8N9E0 | |
| RMPTRRWAPGTQCIT | 41 | P42679 | |
| GWVTPMVPESRTGRS | 231 | Q9NTI7 | |
| TPRMDGSIWLGPNAV | 316 | Q9H9P8 | |
| MSLRVLGSGTWPSAP | 1 | Q9P0G3 | |
| EMGIIPSWGGTTRLV | 186 | Q9NTX5 | |
| SGMRVSWIRQPPGKA | 51 | A0A0C4DH43 | |
| RIPGVPGSMPNASWT | 306 | Q8N0V5 | |
| TWQRPTAAATPDGMR | 856 | Q76N89 | |
| CSRWRMTGQPTITFP | 551 | P46020 | |
| EWPRSTRMLLGPNTV | 116 | Q9NR63 | |
| LSSAWPGTLRSGMVP | 56 | Q9UJY1 | |
| ARMGVSWIRQPPGKA | 51 | A0A0B4J1V2 | |
| VRPRVTNSSPMGWSS | 336 | Q8IY33 | |
| SRWVQVMVLSRPGPL | 251 | Q8TDF6 | |
| GLWRPMRGLNVTATG | 126 | Q96A46 | |
| STQAAPGRVMVWPAV | 36 | Q8N7G0 | |
| MDPSGSRGRPTWVLA | 1 | Q86UK5 | |
| PSTAMNRAAPWGTRR | 1241 | P09848 | |
| TGWPITRVGNPLRYM | 221 | Q8N7C0 | |
| GTMTRPRAGVQWVPT | 1596 | Q6ZVL6 | |
| RTRPWLQELSMGSPG | 321 | Q96N21 | |
| WVDSTPPPGTRVRAM | 146 | P04637 | |
| AVVRGTGSHPWTMAP | 281 | O43347 | |
| TGQPRAPLMTGIAWA | 996 | Q86Y13 | |
| WGFLTPMTVPRIQGL | 461 | Q8NFY9 | |
| MLSSWQGGPRPRQLL | 1 | Q9Y5I0 | |
| PQSVGWMPGLNERTR | 51 | O00459 | |
| ITPRWIVPQSGAMSN | 661 | Q9HCM4 | |
| PVTNTWQPEVSMGTR | 411 | Q6TDP4 | |
| GVGSVMRWPTALPSV | 41 | Q13520 | |
| GGTVTTPWMKDVRLP | 1296 | Q8TD84 | |
| MVSWGGVSIPNSPFR | 746 | P21333 | |
| QMPSAPRLVRAGITW | 476 | Q53EP0 | |
| MELRTPGTKWSPQGI | 1046 | Q8N1P7 | |
| GGVPIQPSVRTQMWL | 286 | Q5SZL2 | |
| GLGWSRSPRLQIPAM | 236 | Q96P31 | |
| GQRVRVSWSPVPGAT | 521 | Q02388 | |
| MSVVPPNRSQTGWPR | 1 | O43809 | |
| RMPTWATPAGQDQSR | 371 | Q9C0E4 | |
| LQPARVTRWGGMIST | 206 | Q9H4P4 | |
| MGWGVRSLQDIPPGT | 1136 | Q9H9B1 | |
| RVGGSMLTPRWSTPE | 1141 | P10586 | |
| VGRSTVIGPGELWMQ | 296 | O14654 | |
| RSQSDDGPIMWVRPG | 521 | Q5VWQ0 | |
| MVPSRRTWNLGATPS | 1 | Q9BVG8 | |
| NPVISQTGSWRRGMT | 1051 | Q8IVL1 | |
| PNWMIGGPDSSRLTS | 441 | Q07837 | |
| WTLVPMPVRVNGSSK | 86 | P48436 | |
| VSHTQRLGRGMPPWP | 966 | Q8WZ75 | |
| VRWRIMGTGPPAFTE | 286 | Q5T4D3 | |
| KAMWRVPGTTRRPVT | 11 | Q96DA0 | |
| TIDTWPGRRSGGMIV | 196 | O75631 | |
| VVTTWRTVMGPRDPN | 241 | Q86XW9 | |
| LRPIWTEMGTPLRGS | 11 | Q6ZTR6 | |
| SCQRTIPMTGKRTWP | 481 | Q8N9V7 | |
| IPGIPVGTMWRFRVQ | 421 | Q96T88 | |
| MTLTRWTGMIIGPPR | 41 | Q15819 | |
| SPWLSPLASMVGGRA | 651 | Q8TEQ8 | |
| ISNIMSVVGVPPGTW | 386 | Q15849 | |
| VETIFLGSRPWMPGT | 361 | O14746 | |
| WRGTSSGFGRPQTML | 936 | Q5TIE3 | |
| LPPGWEMTFTATGQR | 126 | Q9GZV5 | |
| ISVMVTGGPWPTRLS | 126 | Q8WU39 |